BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 2, 2012
View Archived Issues
FDA extends review of Eliquis NDA
Read More
Aastrom Biosciences kicks off enrollment in REVIVE study
Read More
Novel AstraZeneca antibacterials inhibit bifunctional protein
Read More
New calcium-activated potassium channel blocker shows potential in IBD model
Read More
Novel plasma kallikrein inhibitors divulged by Novartis
Read More
Brazilian university patents new vaccines for brucellosis prevention
Read More
Nippon Chemiphar develops novel agents with analgesic potential
Read More
New potential Alzheimer's disease therapies designed in China
Read More
Amylin Pharmaceuticals presents novel glucagon GLP-1 receptor agonists
Read More
Cadila Healthcare investigators identify new PARP-1 inhibitors
Read More
First four-strain flu vaccine approved in U.S.
Read More
Promising phase Ib data reported on QLT-091001
Read More
Bavarian Nordic submits MAA for smallpox vaccine
Read More
Phase II BI-204 trial reaches full enrollment
Read More
Senesco adds second trial site to evaluate SNS01-T in multiple myeloma
Read More
Taiho Pharmaceutical files application to expand Abraxane indications in Japan
Read More
NME efficiently activates type I natural killer T cells
Read More
Helsinn initiates proof-of-concept study of elsiglutide
Read More
Nymox studies BPH drug candidate in new indication
Read More
GSK and Daiichi Sankyo to form joint venture
Read More
Intercell starts second part of C. difficile vaccine candidate trial
Read More
FDA issues safety warning regarding statins
Read More
EryDel reports promising data from phase II EryDex trial
Read More